The revised 2014 GINA strategy report: opportunities for change

Purpose of review This document reviews a major revision of the Global Initiative for Asthma (GINA) Strategy for Asthma Management and Prevention that was published in 2014. The report aimed not only to update evidence-based recommendations for asthma diagnosis and management but also to innovate through a new format and layout to make its recommendations more clinically relevant and easier to implement. Recent findings The GINA 2014 report includes a new definition of asthma that recognizes the heterogeneity of the disease and its phenotypes, and a new chapter about the asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome. Among key messages, the report stresses that therapeutic decisions should be based not only on assessment of symptoms but also on risk factors for exacerbations, side effects of therapy and development of fixed airflow limitation. Asthma management includes not only medications but also nonpharmacological therapies and strategies, in a coordinated and personalized approach to individual patient care. On the basis of evidence about how to achieve behaviour change by health professionals, the recommendations are presented in a user-friendly format, with numerous tables, algorithms and flow-charts facilitating implementation. Background supporting material has been gathered online. Summary The GINA 2014 report provides updated and more easily implementable recommendations on optimal asthma management.

[1]  J Bousquet,et al.  Rapid reduction in hospitalisations after an intervention to manage severe asthma , 2009, European Respiratory Journal.

[2]  E. Bleecker,et al.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.

[3]  Susan Michie,et al.  Changing clinical behaviour by making guidelines specific , 2004, BMJ : British Medical Journal.

[4]  M. Weatherall,et al.  Distinct clinical phenotypes of airways disease defined by cluster analysis , 2009, European Respiratory Journal.

[5]  Gene Feder,et al.  AGREE II: advancing guideline development, reporting and evaluation in health care. , 2010, Journal of clinical epidemiology.

[6]  Michael K Gould,et al.  An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. , 2006, American journal of respiratory and critical care medicine.

[7]  L. Boulet,et al.  The Physicians' Practice Assessment Questionnaire on asthma and COPD. , 2011, Respiratory medicine.

[8]  Jc,et al.  Terminology, Definitions, and Classification of Chronic Pulmonary Emphysema and Related Conditions , 1959 .

[9]  M. Cabana,et al.  Why don't physicians follow clinical practice guidelines? A framework for improvement. , 1999, JAMA.

[10]  S. Straus,et al.  Lost in knowledge translation: Time for a map? , 2006, The Journal of continuing education in the health professions.

[11]  G. Anderson,et al.  Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease , 2008, The Lancet.

[12]  I. Pavord,et al.  An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. , 2009, American journal of respiratory and critical care medicine.

[13]  Kian Fan Chung,et al.  New treatments for severe treatment-resistant asthma: targeting the right patient. , 2013, The Lancet. Respiratory medicine.

[14]  Louise Lemieux-Charles,et al.  How can we improve guideline use? A conceptual framework of implementability , 2011, Implementation science : IS.

[15]  T. Haahtela,et al.  Overlap Syndrome of Asthma and COPD Predicts Low Quality of Life , 2011, The Journal of asthma : official journal of the Association for the Care of Asthma.

[16]  O. Skjønsberg,et al.  How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease? , 2005, Respiratory medicine.

[17]  Matteo Bonini,et al.  Why do doctors and patients not follow guidelines? , 2009, Current opinion in allergy and clinical immunology.

[18]  Marco Lodi,et al.  Inhaler mishandling remains common in real life and is associated with reduced disease control. , 2011, Respiratory medicine.

[19]  J. Grimshaw,et al.  From best evidence to best practice: effective implementation of change in patients' care , 2003, The Lancet.

[20]  B. Quon,et al.  The impact of asthma guidelines , 2010, The Lancet.

[21]  T. Keistinen,et al.  High hospital burden in overlap syndrome of asthma and COPD , 2013, The clinical respiratory journal.

[22]  L. Boulet,et al.  A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care , 2012, European Respiratory Journal.

[23]  G. Guyatt,et al.  GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. , 2011, Journal of clinical epidemiology.

[24]  J. Cosby,et al.  Resilience Engineering: Concepts and Precepts , 2006, Quality and Safety in Health Care.

[25]  J M Grimshaw,et al.  Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. , 1994, Lancet.

[26]  Michelle E. Kho,et al.  AGREE II: advancing guideline development, reporting and evaluation in health care , 2010, Canadian Medical Association Journal.

[27]  L. Boulet,et al.  Major care gaps in asthma, sleep and chronic obstructive pulmonary disease: a road map for knowledge translation. , 2013, Canadian respiratory journal.

[28]  Richard Beasley,et al.  Asthma: Time to confront some inconvenient truths , 2010, Respirology.

[29]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[30]  T. To,et al.  Pan-Canadian REspiratory STandards INitiative for Electronic Health Records (PRESTINE): 2011 national forum proceedings. , 2012, Canadian respiratory journal.

[31]  W. Busse,et al.  The poorly explored impact of uncontrolled asthma. , 2013, Chest.

[32]  S Michie,et al.  Words matter: increasing the implementation of clinical guidelines , 2005, Quality and Safety in Health Care.

[33]  France Légaré,et al.  Adapting clinical practice guidelines to local context and assessing barriers to their use , 2010, Canadian Medical Association Journal.

[34]  J. Grimshaw,et al.  Potential benefits, limitations, and harms of clinical guidelines , 1999, BMJ.